
Jan 22 (Reuters) - CVRx Inc CVRX.O:
CVRX ANNOUNCES INITIATION OF BENEFIT-HF, A LANDMARK HEART FAILURE TRIAL EVALUATING BAROSTIM IN SIGNIFICANTLY EXPANDED POPULATION
CVRX INC - PRIMARY ENDPOINT: ALL-CAUSE MORTALITY AND HEART FAILURE DECOMPENSATION EVENTS
CVRX INC - ENROLLMENT IS EXPECTED TO BEGIN IN THE FIRST HALF OF 2026